ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Diagnostic performance of LI-RADS version 2018 in differentiating hepatocellular carcinoma from other hepatic malignancies in patients with hepatitis B virus infection

Shao, Shuo; Liang, Yingying; Kuang, Sichi; Chen, Jingbiao; Shan, Qungang; Yang, Hao; Zhang, Yao; Wang, Bin; Fowler, Kathryn J.; Wang, Jin*; Sirlin, Claude B.广州医学院; 中山大学; 1
Bosnian Journal of Basic Medical Sciences2020DOI: 10.17305/bjbms.2019.4576
14被引10阅读
引用收藏
分享

摘要

The diagnostic performance of the Liver Imaging Reporting and Data System (LI-RADS) in differentiating hepatocellular carcinoma (HCC) from other hepatic malignancies has not been investigated in Chinese patients with chronic liver disease from hepatitis B virus (HBV) infection. The aim of this study was to evaluate the accuracy of the LI-RADS version 2018 in differentiating HCC, intrahepatic cholangiocarcinoma (ICCA), and combined HCC-cholangiocarcinoma (cHCC-CCA) in Chinese patients with HBV infection. Seventy consecutive HBV-infected patients with ICCA (n = 48) or cHCC-CCA (n = 22) who underwent contrast-enhanced magnetic resonance imaging (CE-MRI) between 2006 and 2017 were enrolled along with a comparison cohort of 70 patients with HCC and CE-MRI-matched for tumor size (10-19 mm, 20-30 mm, 31-50 mm, and >50 mm). Imaging feature frequencies for each tumor type were compared using Fisher's exact test. The classification accuracy of LR-s and LR-M was estimated for HCC versus non-HCC (ICCA and cHCC-CCA). The interobserver agreement was good for LI-RADS categories of HCC and moderate for non-HCC. After consensus read, 66 of 70 (94%) HCCs were categorized LR-5 (including tumor in vein [TIV] with LR-5), while 42 of 48 (88%) ICCAs and 3.3 of 22 (5990 CHCC-CCA s were categorized LR-M (including T IV with LR-M) (p < 0.001). Thus, assignment of LR-5 provided 94% sensitivity and 81% specificity for HCC. LR-M provided 79% sensitivity and 97% specificity for non-HCC (ICCA and cHCC-CCA); and the sensitivity and accuracy were lower in differentiating HCC from non-HCC (tumor size <20 mm). LI-RADS v2018 category 5 and M reliably differentiated HBV-related HCC from ICCA. However, a substantial proportion of cHCC-CCAs were categorized LR-s rather than LR-M. While management is controversial for these combined tumors, accurate prospective differentiation is desired for optimal treatment.

学科与关键词

关键词
Hepatocellular carcinomaHCCintrahepatic cholangiocarcinomaICCAcombined HCC-cholangiocarcinomacHCC-CCAhepatitis B virusHBVLiver Imaging Reporting and Data System (LI-RADS)
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Bosnian Journal of Basic Medical Sciences
发表日期
2020
卷期
第 20 卷, 第 3 期
页码
401-410
DOI
10.17305/bjbms.2019.4576
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
4区
成果收录
SCIE
资助标注
Science and Technology Program of Guangzhou, China [201704020016]; National Natural Science Foundation of China [91959118]; Clinical Research Foundation of the 3rd Affiliated Hospital of Sun Yat-Sen University [YHJH201901]

作者

  • S

    Shao, Shuo (第一作者)

    1 · jining med univ · sun yat sen univ

  • L

    Liang, Yingying

    2 · 1 · guangzhou med univ

查看全部 11 位作者收起作者
  • K

    Kuang, Sichi

    sun yat sen univ

  • C

    Chen, Jingbiao

    sun yat sen univ

  • S

    Shan, Qungang

    sun yat sen univ

  • Y

    Yang, Hao

    sun yat sen univ

  • Z

    Zhang, Yao

    sun yat sen univ

  • W

    Wang, Bin

    binzhou med univ

  • F

    Fowler, Kathryn J.

  • W

    Wang, Jin (通讯)

    sun yat sen univ

  • S

    Sirlin, Claude B.

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417